AzTrials
AzTrials

Cancer SurvivorsCAPABLENCT03750981

C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)

A study testing 12 week pilot intervention study. in people with Cancer Survivors, run by Barbara Ann Karmanos Cancer Institute at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cancer Survivors
What is being tested?
12 week pilot intervention study.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteUnited States
Study dates
12 Nov 2018to 30 Nov 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or older at time of program recruitment
  • Diagnosed with any cancer
  • Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
  • Available transportation to and from the facility on session days

Who cannot join

  • Widely metastatic cancers to the brain or bone may be excluded.
  • Patients using mobility assistance devices may be excluded. Exclusionary criteria will be reviewed on a case-by-case basis and patients with these limitations may be included with approval from Dr. Beebe-Dimmer and the referring physician.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jennifer B Beebe-Dimmer, MPH, PhD. contact

(313) 578-4209

dimmerj@karmanos.org

Tara Baird, M.Ed. contact

(313) 578-4246

bairdt@karmanos.org

United States1 site, 1 recruiting
  • Barbara Ann Karmanos Cancer Institute

    Detroit, Michigan, 48201

    Tara Baird, (313) 578-4246, bairdt@karmanos.org

    Recruiting

Other trials in United States

About this study

Official title: Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Study of CrossFit® in Cancer Survivors

This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.

Read the detailed description

A 12-week pilot intervention study introducing a high-intensity functional training program to 100 cancer survivors and evaluate the effects of this program on patient quality of life, functional capacity, and body composition. Response rates will be determined using various recruitment methods and estimate differences in response rates by patient characteristics including race, gender and age. Barriers to participation in the program in contacted patients who do not enroll as well as patients who enroll and do not complete the program will be described, as will participant satisfaction with enrolled participants who complete the program. The goal of this pilot study is to help refine the recruitment and program methods for a larger intervention study to test the superiority of a high-intensity interval functional training program compared with current American Cancer Society guidelines in improving functional capacity, body composition and patient reported quality of life.

Surveys will be completed by each participant weekly and physical assessments will be completed monthly.

Being tested
12 week pilot intervention study.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 12 week pilot intervention study.Behavioural

    Participants will begin a 12-week high-intensity functional training program conducted at CrossFit® in the D, located in downtown Detroit, Northville Athletix in Northville and Five Lakes CrossFit® in Farmington Hills.

Study groups in NCT03750981
Study groupRoleWhat they receive
A 12-week pilot intervention study introducing a high-intensiOtherNot described
Receives: Behavioral: 12 week pilot intervention study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Enrollment rates

    Enrollment rates will be calculated among those who respond to notices about the study and adherence to the program among those who enroll and to describe reported barriers to participation among respondents who do not ultimately enroll

    Measured: Baseline

  2. Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program

    Physical measures of strength will be assessed by a certified trainer. To assess strength improvements deadlifts (lifting weights from floor to waist) will be performed in 10 lb. increments. A circuit will also be done with strength measures including sit ups and push ups.

    Measured: Baseline to 12 weeks

  3. Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program

    Physical measures of flexibility will be assessed by a certified trainer. To assess flexibility sit ups, squats and push up level (floor, knees, on an elevated bar, etc) will be recorded.

    Measured: Baseline to 12 weeks

  4. Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program

    Physical measures of cardiovascular strength will be assessed by a certified trainer. To assess cardiovascular strength maximum effort on a stationary bike will be recorded. Additionally, in the circuit, a maximum effort on a rowing machine will be recorded.

    Measured: Baseline to 12 weeks

  5. Change in self-reported health-related quality of life (HRQOL) and variability using the FACT questionnaire

    Quality of Life will be measured using the Functional Assessment of Cancer Therapy: General (FACT), developed by Dr. David Cella. The FACT-G is 27 items assessing physical, social/ family, emotional and functional well-being. The survey uses a five-point scale from 0 (not at all) to 4 (very much). Scoring the FACT-G is performed through a sum of item scores. Higher scores indicate a better health state.

    Measured: Baseline to 12 weeks

  6. Change in Body Composition

    Changes in weight in kg

    Measured: Baseline to 12 weeks

  7. Change in Body Composition

    Changes in body fat percentage

    Measured: Baseline to 12 weeks

  8. Change in Body Composition

    Changes in visceral fat percentage

    Measured: Baseline to 12 weeks

  9. Change in Body Composition

    Changes in muscle mass percentage

    Measured: Baseline to 12 weeks

  10. Change in Body Composition

    Changes in body mass index (BMI) - Weight and height will be combined to report BMI in kg/ m2

    Measured: Baseline to 12 weeks

  11. Change in Body Composition

    Changes in resting metabolism value

    Measured: Baseline to 12 weeks

  12. Change in Motivation

    Motivation to exercise will be collected via a survey

    Measured: Baseline to 12 weeks

  13. Satisfaction with the Program

    Satisfaction with the program will be collected via a survey

    Measured: 12 weeks

  14. Program Adherence

    Program adherence will be calculated based on how many sessions each participant attended in the 13 week program, 36 session design.

    Measured: 12 weeks

  15. Height

    Height will be collected in meters to use in the calculation of Body Mass Index

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2018
  2. Study start12 Nov 2018
  3. Primary completion30 Nov 2027 (estimated)
  4. Study completion30 Nov 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03750981
Sponsor's protocol ID
2018-091
Acronym
CAPABLE
Status last verified
Nov 2025
First submitted
15 Nov 2018
Last updated
6 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 12 week pilot intervention study. in people with Cancer Survivors, run by Barbara Ann Karmanos Cancer Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jennifer B Beebe-Dimmer, MPH, PhD. ((313) 578-4209, dimmerj@karmanos.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Enrollment rates (time frame: Baseline). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in